Drug-Induced Erectile Dysfunction
Antihypertensives, SSRIs, Finasteride, Opioids, Antipsychotics
Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Class effect noted in many FDA labels
Reference only. Not medical advice.
What can go wrong
The major risk is misattribution: ED is treated as primary disease while the offending drug continues, or conversely an essential medication (e.g. for blood pressure or depression) is stopped abruptly by a patient acting alone, risking rebound hypertension or relapse. Medication changes for sexual side effects should always be made with the prescribing clinician.
This is something to take to a clinician. The Atlas can tell you what is known about drug-induced erectile dysfunction in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
A large fraction of erectile dysfunction is iatrogenic, driven by prescription medications rather than primary vascular or hormonal disease. Thiazide diuretics, non-selective beta-blockers, SSRIs/SNRIs, 5-alpha-reductase inhibitors, opioids, and many antipsychotics are repeatedly implicated. Estimates commonly cite that roughly a quarter of ED cases have a contributing pharmacological component. Recognizing a drug cause is important because the dysfunction is frequently reversible with substitution or dose adjustment under physician guidance.
Sometimes the cause of ED is sitting in the medicine cabinet.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Mechanisms vary by class. Thiazide diuretics and non-selective beta-blockers reduce penile perfusion and sympathetic-parasympathetic balance. SSRIs raise serotonergic tone, which suppresses libido, delays orgasm, and can impair erection. Opioids suppress the hypothalamic-pituitary-gonadal axis, lowering testosterone (opioid-induced androgen deficiency). 5-alpha-reductase inhibitors lower dihydrotestosterone. Antipsychotics and some antidepressants raise prolactin, which suppresses gonadal function.
Safety in detail
Do not start, stop, or change prescription medications to address sexual side effects without consulting the prescribing physician. Some of these drugs treat life-threatening conditions, and abrupt discontinuation carries its own documented risks.
What has to be monitored
The bloodwork this needs, and the reason it belongs with a clinician rather than a website.
- Medication and timeline review at ED presentation
- Blood pressure if antihypertensives are changed
- Mood and relapse monitoring if antidepressants are changed
- Testosterone and prolactin where opioid or antipsychotic use is involved
What people get wrong
Often saidMy ED has to be a circulation or testosterone problem
ActuallyMedication review comes first. A drug started in the months before symptoms began is a leading suspect, and the fix may be a supervised substitution rather than a new prescription.
Often saidIf a drug causes ED I should just stop it
ActuallyStopping antihypertensives, antidepressants, or other essential drugs without medical guidance can be more dangerous than the side effect. Switching within a class or to an alternative is a physician decision.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Common culprits
- Thiazides, non-selective beta-blockers, SSRIs, finasteride, opioids
- Often reversible
- With supervised substitution
- Frequently missed
- Patients rarely volunteer the symptom
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Drug-Induced Erectile Dysfunction. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Treatment of Mild Hypertension Study (TOMHS)1997
Documented differing rates of erectile dysfunction across antihypertensive classes
SSRI sexual dysfunction reviewsestablished
Sexual side effects reported in a substantial minority to majority of SSRI users depending on agent and definition
Opioid-induced androgen deficiency literatureestablished
Chronic opioid use associated with suppressed testosterone and sexual dysfunction